• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    2.18 Down 0.02(0.91%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development16,182  15,653  16,208  18,761  
    Selling General and Administrative4,150  4,241  3,241  2,940  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (20,332) (19,894) (19,449) (21,701)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes(20,332)(19,894)(19,449)(21,701)
    Interest Expense375  458  517  585  
    Income Before Tax(20,707)(20,352)(19,966)(22,286)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(20,707)(20,352)(19,966)(22,286)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (20,707) (20,352) (19,966) (22,286)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (20,707) (20,352) (19,966) (22,286)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.